Source:http://linkedlifedata.com/resource/pubmed/id/16596047
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2006-4-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1527-5299
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
110-1
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading | |
pubmed:articleTitle |
BiDil (isosorbide dinitrate and hydralazine hydrochloride).
|
pubmed:affiliation |
Department of Medicine, Section of Clinical Pharmacology and Hypertension, Division of Nephrology, Virginia Commonwealth University, Richmond, VA, USA.
|
pubmed:publicationType |
Journal Article
|